Clinical Trial Update: Psilocybin on Brain Mechanisms of Motivation in OUD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating psilocybin for opioid use disorder, focusing on brain mechanisms of motivation. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Anna Rose Childress, Ph.D. | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING